CD4 and non-small cell lung carcinoma: Importantly, we have previously shown using flow cytometry that the vast majority of T cells in NSCLC tumors were either CD3+CD4+ or CD3+CD8+, with very few CD3+ T cells being CD4-CD8- double-negative (6).